These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33145430)

  • 1. Serum concentrations of selected adipokines in virus-related liver cirrhosis and hepatocellular carcinoma.
    Pazgan-Simon M; Zuwała-Jagiełło J; Kukla M; Grzebyk E; Simon K
    Clin Exp Hepatol; 2020 Sep; 6(3):235-242. PubMed ID: 33145430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum visfatin and vaspin levels in hepatocellular carcinoma (HCC).
    Pazgan-Simon M; Kukla M; Zuwała-Jagiełło J; Derra A; Bator M; Menżyk T; Lekstan A; Grzebyk E; Simon K
    PLoS One; 2020; 15(1):e0227459. PubMed ID: 31935230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of serum visfatin and vaspin in hepatocellular carcinoma in hepatitis C-related liver cirrhosis.
    Abdelhamed W; Morsy KH; Hefny HM; Abudeif A
    Clin Exp Hepatol; 2023 Sep; 9(3):210-220. PubMed ID: 37790689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum betatrophin and irisin levels in hepatocellular carcinoma.
    Pazgan-Simon M; Zuwala-Jagiello J; Menzyk T; Bator M; Derra A; Lekstan A; Grzebyk E; Simon K; Kukla M
    J Physiol Pharmacol; 2020 Feb; 71(1):. PubMed ID: 32554846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Possible Role of Adipokines in HCV Associated Hepatocellular Carcinoma.
    El-Daly UM; Saber MM; Abdellateif MS; Nassar HR; Namour AE; Ismail YM; Zekri AN
    Asian Pac J Cancer Prev; 2020 Mar; 21(3):599-609. PubMed ID: 32212784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of adipokines and hepatitis B virus on histological liver injury in the Chinese.
    Wong VW; Wong GL; Yu J; Choi PC; Chan AW; Chan HY; Chu ES; Cheng AS; Chim AM; Chan FK; Sung JJ; Chan HL
    Am J Gastroenterol; 2010 Jan; 105(1):132-8. PubMed ID: 19809411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating visfatin level is associated with hepatocellular carcinoma in chronic hepatitis B or C virus infection.
    Tsai IT; Wang CP; Yu TH; Lu YC; Lin CW; Lu LF; Wu CC; Chung FM; Lee YJ; Hung WC; Hsu CC
    Cytokine; 2017 Feb; 90():54-59. PubMed ID: 27770715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: a prospective study in taiwan.
    Chen CL; Yang WS; Yang HI; Chen CF; You SL; Wang LY; Lu SN; Liu CJ; Kao JH; Chen PJ; Chen DS; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1659-71. PubMed ID: 24895413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of high-sensitivity C-reactive protein tests for the diagnosis of hepatocellular carcinoma in patients with hepatitis B-associated liver cirrhosis.
    Ma LN; Liu XY; Lu ZH; Wu LG; Tang YY; Luo X; Hu YC; Yan TT; Wang Q; Ding XC; Xie Y
    Oncol Lett; 2017 May; 13(5):3457-3464. PubMed ID: 28521452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS
    Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.
    Chu CM
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E25-30. PubMed ID: 10921378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.
    Mazziotti G; Sorvillo F; Morisco F; Carbone A; Rotondi M; Stornaiuolo G; Precone DF; Cioffi M; Gaeta GB; Caporaso N; Carella C
    Cancer; 2002 Dec; 95(12):2539-45. PubMed ID: 12467068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum miRNA-27a and miRNA-18b as potential predictive biomarkers of hepatitis C virus-associated hepatocellular carcinoma.
    Rashad NM; El-Shal AS; Shalaby SM; Mohamed SY
    Mol Cell Biochem; 2018 Oct; 447(1-2):125-136. PubMed ID: 29455432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance, adipokine profile and hepatic expression of SOCS-3 gene in chronic hepatitis C.
    Wójcik K; Jabłonowska E; Omulecka A; Piekarska A
    World J Gastroenterol; 2014 Aug; 20(30):10449-56. PubMed ID: 25132761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic hepatitis B virus infection in Asian countries.
    Merican I; Guan R; Amarapuka D; Alexander MJ; Chutaputti A; Chien RN; Hasnian SS; Leung N; Lesmana L; Phiet PH; Sjalfoellah Noer HM; Sollano J; Sun HS; Xu DZ
    J Gastroenterol Hepatol; 2000 Dec; 15(12):1356-61. PubMed ID: 11197043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
    Macías Rodríguez MA; Rendón Unceta P; Tejada Cabrera M; Infante Hernández JM; Correro Aguilar F; Díaz García F; Benítez Rodríguez E; Mangas Rojas A; Martín Herrera L
    Rev Esp Enferm Dig; 2000 Jul; 92(7):458-69. PubMed ID: 11026763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connective tissue growth factor (CTGF/CCN2) in serum is an indicator of fibrogenic progression and malignant transformation in patients with chronic hepatitis B infection.
    Gressner OA; Fang M; Li H; Lu LG; Gressner AM; Gao CF
    Clin Chim Acta; 2013 Jun; 421():126-31. PubMed ID: 23501329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of hepatocellular carcinoma. Evaluation of viral and other risk factors in a low-endemic area for hepatitis B and C.
    Peters M; Wellek S; Dienes HP; Junginger T; Meyer J; Meyer Zum Büschendfelde KH; Gerken G
    Z Gastroenterol; 1994 Mar; 32(3):146-51. PubMed ID: 8197809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated adiponectin and sTNFRII serum levels can predict progression to hepatocellular carcinoma in patients with compensated HCV1 cirrhosis.
    Bastard JP; Fellahi S; Audureau É; Layese R; Roudot-Thoraval F; Cagnot C; Mahuas-Bourcier V; Sutton A; Ziol M; Capeau J; Nahon P;
    Eur Cytokine Netw; 2018 Sep; 29(3):112-120. PubMed ID: 30547888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.